November 28, 2016 - By Marguerite Chambers
Norman Hames, the Executive Vice President of Radnet Inc, made a sale of 7,322 shares of the company, worth total $44,799 US Dollars, based on an average weighted cost of $6.1 for share. Norman Hames possess exactly 1.35% of Radnet Inc’s market capitalization or 623,550 shares.
Out of 3 analysts covering RadNet (NASDAQ:RDNT), 1 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 33% are positive. $9 is the highest target while $8 is the lowest. The $8.50 average target is 39.34% above today’s ($6.1) stock price. RadNet has been the topic of 3 analyst reports since March 15, 2016 according to StockzIntelligence Inc. The rating was initiated by Sidoti with “Buy” on Friday, April 15. The firm earned “Hold” rating on Tuesday, March 15 by Jefferies. The stock has “Neutral” rating given by Sterne Agee CRT on Thursday, June 2.
Insitutional Activity: The institutional sentiment decreased to 1.08 in 2016 Q2. Its down 0.47, from 1.55 in 2016Q1. The ratio worsened, as 10 funds sold all RadNet Inc. shares owned while 23 reduced positions. 13 funds bought stakes while 38 increased positions. They now own 21.64 million shares or 1.94% more from 21.22 million shares in 2016Q1.
Alpine Woods Ltd Liability reported 17,336 shares or 0.01% of all its holdings. The Pennsylvania-based Pnc Financial Serv Grp Inc has invested 0% in RadNet Inc. (NASDAQ:RDNT). Globeflex Limited Partnership holds 0.18% of its portfolio in RadNet Inc. (NASDAQ:RDNT) for 119,905 shares. Citigroup, a New York-based fund reported 18,962 shares. Moreover, Dimensional Fund Advisors Ltd Partnership has 0% invested in RadNet Inc. (NASDAQ:RDNT) for 1.24 million shares. Morgan Stanley last reported 184,503 shares in the company. Moreover, Metropolitan Life Insurance Company Ny has 0% invested in RadNet Inc. (NASDAQ:RDNT) for 31,163 shares. Eidelman Virant holds 0.03% or 10,000 shares in its portfolio. Moreover, State Street has 0% invested in RadNet Inc. (NASDAQ:RDNT) for 554,940 shares. Raymond James And Assoc has 14,151 shares for 0% of their US portfolio. Css Limited Liability Company Il owns 11,522 shares or 0% of their US portfolio. Cheyne Capital Mngmt (Uk) Llp reported 268,907 shares or 1.16% of all its holdings. Blackrock Fund Advsr accumulated 962,698 shares or 0% of the stock. Manufacturers Life The, a Ontario – Canada-based fund reported 29,035 shares. Moreover, Teachers Advsrs Inc has 0% invested in RadNet Inc. (NASDAQ:RDNT) for 55,926 shares.
Insider Transactions: Since August 12, 2016, the stock had 0 buys, and 3 selling transactions for $557,238 net activity. 20,000 shares were sold by Forthuber Stephen M, worth $143,600 on Monday, September 19. LINDEN JEFFREY L also sold $192,300 worth of RadNet Inc. (NASDAQ:RDNT) shares. 35,414 shares were sold by STOLPER MARK, worth $221,338 on Friday, August 12.
The stock decreased 1.61% or $0.1 during the last trading session, hitting $6.1. About 114,863 shares traded hands. RadNet Inc. (NASDAQ:RDNT) has risen 18.32% since April 25, 2016 and is uptrending. It has outperformed by 12.31% the S&P500.
RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company has a market cap of $290.48 million. The Firm operates directly or indirectly through joint ventures with hospitals, approximately 300 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. It has a 64.35 P/E ratio. The Company’s centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders.
According to Zacks Investment Research, “RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.”
Analysts await RadNet Inc. (NASDAQ:RDNT) to report earnings on March, 13. They expect $0.11 earnings per share, up 57.14% or $0.04 from last year’s $0.07 per share. RDNT’s profit will be $5.24M for 13.86 P/E if the $0.11 EPS becomes a reality. After $0.04 actual earnings per share reported by RadNet Inc. for the previous quarter, Wall Street now forecasts 175.00% EPS growth.
More news for RadNet Inc. (NASDAQ:RDNT) were recently published by: Marketwatch.com, which released: “/quotes/zigman/3870025/realtime” on November 16, 2010. Prnewswire.com‘s article titled: “RadNet, Inc., a national leader in outpatient diagnostic imaging, selects ..” and published on July 26, 2016 is yet another important article.
RadNet, Inc., incorporated on June 19, 2008, is a well-known provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Firm operates directly or indirectly through joint ventures with hospitals, approximately 300 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. The Company’s centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. The Company’s services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Firm operates approximately 140 fixed-site, freestanding outpatient diagnostic imaging facilities in California, over 10 in Delaware, three in Florida, 50 in Maryland, 20 in New Jersey, 20 in the Rochester and Hudson Valley areas of New York, approximately 40 in New York City, as well as five in Rhode Island.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.